Risk factor
Limited trading liquidity
Profitability factor
Excellent dividends
About
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus...
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITD.
Target Price
The average target price of 4595.T is 1500 and suggests 19% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
Buy
Sell